UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy

Journal of biomedical science, 2022-02, Vol.29 (1), p.12-27, Article 12

2022

Volltextzugriff (PDF)

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VIII: CAR-T cells: preclinical development - Safety and efficacy evaluation

Hematology, Transfusion and Cell Therapy, 2021-11, Vol.43 (Suppl 2), p.S54-S63

2021

Volltextzugriff (PDF)

Transposon-mediated generation of CAR-T cells shows efficient anti B-cell leukemia response after ex vivo expansion

Gene therapy, 2020-02, Vol.27 (1-2), p.85-95

2020

Volltextzugriff (PDF)

Survival advantage of native and engineered T cells is acquired by mitochondrial transfer from mesenchymal stem cells

Journal of translational medicine, 2024-09, Vol.22 (1), p.868-15, Article 868

2024

Volltextzugriff (PDF)

The prevalence and prognostic impact of tumor-infiltrating lymphocytes in uterine carcinosarcoma

BMC cancer, 2021-12, Vol.21 (1), p.1306-1306, Article 1306

2021

Volltextzugriff (PDF)

CRISPR/Cas-9 vector system: targets UL-39 and inhibits Simplexvirus humanalpha1 (HSV-1) replication in vitro

Cellular and Molecular Biology, 2023-07, Vol.69 (7), p.19-23

2023

Volltextzugriff (PDF)

Development of CAR-T cell therapy for B-ALL using a point-of-care approach

Oncoimmunology, 2020-01, Vol.9 (1), p.1752592-1752592

2020

Volltextzugriff (PDF)

In silico and in vivo analysis reveal impact of c-Myc tag in FMC63 scFv-CD19 protein interface and CAR-T cell efficacy

Computational and structural biotechnology journal, 2024-12, Vol.23, p.2375-2387

2024

Volltextzugriff (PDF)

Transcriptional characterization of immunological infiltrates and their relation with glioblastoma patients overall survival

Oncoimmunology, 2018-06, Vol.7 (6), p.e1431083

2018

Volltextzugriff (PDF)

Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms

HemaSphere, 2021-07, Vol.5 (7), p.e593-n/a

2021

Volltextzugriff (PDF)

Cell-Penetrating Peptides and CRISPR-Cas9: A Combined Strategy for Human Genetic Disease Therapy

Human gene therapy, 2024-10, Vol.35 (19-20), p.781-797

2024

Volltextzugriff (PDF)

Structural Determinants of Chimeric Antigen Receptor Design

Critical reviews in immunology, 2021, Vol.41 (1), p.89-104

2021

Volltextzugriff (PDF)

An efficient low cost method for gene transfer to T lymphocytes

PloS one, 2013-03, Vol.8 (3), p.e60298

2013

Volltextzugriff (PDF)

The CRISPR/Cas System in Human Cancer

Genome Editing in Biomedical Sciences, 2023, Vol.1429, p.59-71

2023

Volltextzugriff (PDF)

CRISPR/Cas 9 system for the treatment of dilated cardiomyopathy: A hypothesis related to function of a MAP kinase

Medical hypotheses, 2019-07, Vol.128, p.91-93

2019

Volltextzugriff (PDF)

PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells

Tumor biology, 2016-08, Vol.37 (8), p.11339-11348

2016

Volltextzugriff (PDF)

Genetic instability in the tumor microenvironment: a new look at an old neighbor

Molecular cancer, 2015-07, Vol.14 (1), p.145, Article 145

2015

Volltextzugriff (PDF)

CAR-T cells leave the comfort zone: current and future applications beyond cancer

Immunotherapy advances, 2021-01, Vol.1 (1), p.ltaa006

2021

Volltextzugriff (PDF)

An Efficient Electroporation Protocol for the Genetic Modification of Mammalian Cells

Frontiers in bioengineering and biotechnology, 2017-01, Vol.4, p.99-99

2017

Volltextzugriff (PDF)

TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells

Stem cell research, 2020-04, Vol.44, p.101755-101755, Article 101755

2020

Volltextzugriff (PDF)

Immunological-based approaches for cancer therapy

Clinics (São Paulo, Brazil), 2018-01, Vol.73 (suppl 1), p.e429s, Article e429s

2018

Volltextzugriff (PDF)

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VII. Present and future of technologies for production of CAR cell therapies

Hematology, Transfusion and Cell Therapy, 2021-11, Vol.43 (Suppl 2), p.S46-S53

2021

Volltextzugriff (PDF)

Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms

HemaSphere, 2021-07, Vol.5 (7)

2021

Volltextzugriff (PDF)

Moving receptor redirected adoptive cell therapy toward fine tuning of antitumor responses

International reviews of immunology, 2014-09, Vol.33 (5), p.402-416

2014

Volltextzugriff (PDF)

Agathisflavone enhances retinoic acid-induced neurogenesis and its receptors α and β in pluripotent stem cells

Stem cells and development, 2011-10, Vol.20 (10), p.1711-1721

2011

Volltextzugriff (PDF)

1 – 25 von 36

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(35)
Mit Volltextzugriff
(31)

Publikationsform

Artikel
(35)
Buchkapitel
(1)

Sprache

Englisch
(34)
Portugiesisch
(2)

Erscheinungsjahr

n.n

Thema

Science & Technology
(29)
Life Sciences & Biomedicine
(28)
Humans
(18)
Hematology
(9)
Animals
(7)
Immunotherapy
(7)
Medicine, Research & Experimental
(7)
Oncology
(7)
Research & Experimental Medicine
(7)
Biotechnology & Applied Microbiology
(6)
Cell Biology
(6)
Immunology
(6)
Cancer
(5)
Chimeric Antigen Receptor
(5)
Female
(5)
Antigens
(4)
B Cells
(4)
Biochemistry & Molecular Biology
(4)
Gene Expression
(4)
Gene Therapy
(4)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

The ambiguous role of obesity in oncology by promoting cancer but boosting antitumor immunotherapy

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VIII: CAR-T cells: preclinical development - Safety and efficacy evaluation

Transposon-mediated generation of CAR-T cells shows efficient anti B-cell leukemia response after ex vivo expansion

Survival advantage of native and engineered T cells is acquired by mitochondrial transfer from mesenchymal stem cells

The prevalence and prognostic impact of tumor-infiltrating lymphocytes in uterine carcinosarcoma

CRISPR/Cas-9 vector system: targets UL-39 and inhibits Simplexvirus humanalpha1 (HSV-1) replication in vitro

Development of CAR-T cell therapy for B-ALL using a point-of-care approach

In silico and in vivo analysis reveal impact of c-Myc tag in FMC63 scFv-CD19 protein interface and CAR-T cell efficacy

Transcriptional characterization of immunological infiltrates and their relation with glioblastoma patients overall survival

Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms

Cell-Penetrating Peptides and CRISPR-Cas9: A Combined Strategy for Human Genetic Disease Therapy

Structural Determinants of Chimeric Antigen Receptor Design

An efficient low cost method for gene transfer to T lymphocytes

The CRISPR/Cas System in Human Cancer

CRISPR/Cas 9 system for the treatment of dilated cardiomyopathy: A hypothesis related to function of a MAP kinase

PCA3 long noncoding RNA modulates the expression of key cancer-related genes in LNCaP prostate cancer cells

Genetic instability in the tumor microenvironment: a new look at an old neighbor

CAR-T cells leave the comfort zone: current and future applications beyond cancer

An Efficient Electroporation Protocol for the Genetic Modification of Mammalian Cells

TET2 haploinsufficiency alters reprogramming into induced pluripotent stem cells

Immunological-based approaches for cancer therapy

Associação Brasileira de Hematologia, Hemoterapia e Terapia Celular Consensus on genetically modified cells. VII. Present and future of technologies for production of CAR cell therapies

Induced Pluripotent Stem Cells Enable Disease Modeling and Drug Screening in Calreticulin del52 and ins5 Myeloproliferative Neoplasms

Moving receptor redirected adoptive cell therapy toward fine tuning of antitumor responses

Agathisflavone enhances retinoic acid-induced neurogenesis and its receptors α and β in pluripotent stem cells

Suchergebnisse filtern